FDA 483 - GreenMark Biomedical Inc. - April 18, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of GreenMark Biomedical Inc. in Ann Arbor, MI, a manufacturer of medical devices, revealed significant deficiencies across its quality system. The firm failed to document supplier evaluations, adequately monitor production processes, and maintain records for incoming product acceptance. Additionally, management reviews were not conducted, Unique Device Identifiers were not uploaded to the GUDID database, and raw data for equipment operational qualifications were unavailable.
ID · ea962d7c-87f0-4bbd-8501-0b3034e42440